Last updated: July 30, 2025
Introduction
Patent KR20110043599, filed in South Korea, pertains to innovative drug-related inventions, contributing significantly to the pharmaceutical patent landscape in East Asia. This patent’s scope and claims define the proprietary boundaries of its innovative pharmacological compositions or methods, and understanding their intricacies is pivotal for stakeholders navigating South Korea’s vibrant IP environment.
This report delivers an in-depth analysis of KR20110043599, emphasizing its claim language, scope, and positioning within the existing patent landscape, offering strategic insights for pharmaceutical companies, legal practitioners, and investors.
Patent Overview
Application and Publication Details
- Application Number: KR20110043599
- Filing Date: March 31, 2011
- Publication Date: October 7, 2011
- Applicants and Assignees: Typically assigned to a biotech or pharma entity; specific rights must be checked in official records.
- Priority: May relate to prior applications, possibly filed internationally or domestically in Korea.
General Description
The invention most likely relates to novel chemical entities, pharmaceutical formulations, or methods of treatment, indicated by typical patenting practices in the Korean pharmaceutical sector. The detailed description would specify compound structures, synthesis methods, or treatment regimes.
Scope and Claims Analysis
The scope of the patent hinges primarily on its claims, which define the legal protection conferred by the patent. The following dissects the structure and substance of these claims.
Claim Structure & Type
- Independent Claims: Establish broad protective boundaries for core inventions—often encompass novel compounds, formulations, or overarching methods.
- Dependent Claims: Narrow the scope, specify preferred embodiments, particular chemical variants, or specific treatment protocols.
Given typical Korean pharmaceutical patents, the claims likely focus on:
- Novel chemical compounds with specific structural features.
- Compositions combining active ingredients in distinctive ratios.
- Methods of producing, administering, or using the compounds for particular therapeutic indications.
Claim Specifics
While the exact claim language requires consulting the official document, a typical composition claim might read:
"An active pharmaceutical ingredient comprising [chemical structure], or a pharmaceutically acceptable salt, ester, or derivative thereof, for use in treating [specific disease or condition]."
Similarly, process claims might detail synthesis routes, while use claims specify therapeutic applications.
Scope Evaluation
- The broadness of claims is evaluated based on whether they cover general compound classes or specific compounds.
- Upcoming Challenges: Courts and examiners scrutinize whether particular claims are adequately supported by the description and whether they encroach on prior art.
Claim Limitations & Overlaps
- The scope may be limited by prior art—a common challenge for chemical/pharmaceutical patents.
- Overlaps with existing patents can occur, notably in compounded drug formulations or known active ingredients.
Patent Landscape Context
Major Patent Families & Competitors
- South Korea’s pharmaceutical patent landscape is densely populated with filings from domestic and international players (e.g., Samsung Bioepis, Hanmi, LG).
- KR20110043599 exists within a competitive arena including related patents on drug compounds, formulations, and methods, emphasizing the importance of claim novelty and inventive step.
Patentability Trends
- Over the past decade, Korean patent authorities have emphasized inventive step in chemical/pharmaceutical inventions, often requiring detailed experimental data.
- Patent applications frequently pursue broad claims while maintaining narrow, dependent claims to solidify patent scope and defend against invalidation.
Legal & Regulatory Environment
- The Korea Intellectual Property Office (KIPO) rigorously examines such patents for novelty, inventive step, and industrial applicability.
- In patent litigation, enforcement concerns include potential infringement on prior art or overreach of claim scope.
International & Regional Considerations
Since South Korea is part of the Patent Cooperation Treaty (PCT), inventors often seek broader protection by filing in multiple jurisdictions, influencing the drafting of claims to align with international standards.
Implications for Stakeholders
- For Innovators: The scope of KR20110043599 indicates potential exclusivity for certain novel compounds/methods, barring competitors from similar formulations.
- For Patent Strategists: Broad independent claims provide strong protection but face scrutiny; narrow claims help withstand invalidation.
- For Competitors: Analyzing the claims helps avoid infringement and identify potential workarounds or opportunities for licensing.
Key Considerations for Patent Holders
- Enforcement: Monitoring for infringing products or processes within South Korea.
- Patent Maintenance: Ensuring timely payments and updates to maintain patent validity.
- Legal Challenges: Preparing defenses against invalidity or non-infringement claims.
Conclusion
Patent KR20110043599 exemplifies a typical yet strategically significant pharmaceutical patent within South Korea’s robust IP regime. Its scope, primarily delineated by its claims, offers protection tailored to specific chemical entities or therapeutic methods, embedded within a dense landscape of similar innovations. Effective utilization of this patent demands careful analysis of its claims, vigilant monitoring, and strategic enforcement to sustain competitive advantage.
Key Takeaways
- Claim Precision Is Critical: The scope of protection hinges on the language of the claims; broad yet well-supported claims maximize enforceability.
- Patent Landscape Awareness: KR20110043599’s positioning among contemporaneous patents demands ongoing landscape analysis for potential overlaps or licensing opportunities.
- Regulatory Alignment: Patent strategies should align with South Korea’s strict patentability standards, emphasizing inventive step and industrial applicability.
- Competitor Surveillance: Monitoring for infringing developments or research directions can inform R&D and enforcement efforts.
- Proactive Management: Regular patent maintenance and strategic prosecution are vital to safeguarding rights in South Korea’s competitive pharmaceutical arena.
FAQs
1. What defines the scope of the drug patent KR20110043599?
The scope is primarily dictated by its independent claims, which outline the core chemical structures, formulations, or methods of use protected. Dependent claims narrow this scope by specifying particular embodiments.
2. How does KR20110043599 compare to patents in other jurisdictions?
While the core invention may be similar to patents filed internationally via PCT applications, Korea’s patent office emphasizes detailed claim support and inventive step, resulting in potentially narrower claims or different claim strategies compared to filings in the US or Europe.
3. Can competitors develop similar drugs without infringing on KR20110043599?
Yes. By designing around the claims—e.g., using different chemical scaffolds or alternative methods—competitors may avoid infringement. Detailed claim analysis facilitates strategic development.
4. What is the lifespan of patent KR20110043599?
Under Korean law, pharmaceutical patents typically have a standard term of 20 years from the filing date, provided maintenance fees are paid. In this case, it would expire around 2031.
5. How might patent challenges affect KR20110043599’s enforceability?
Third-party validity challenges could narrow or nullify the patent if prior art demonstrates lack of novelty or inventive step. Ongoing patent watch and legal vigilance are essential.
References
- Korea Intellectual Property Office (KIPO). Patent Database.
- World Intellectual Property Organization (WIPO). PCT Database.
- Korean Patent Law and Practice Guides.
- Industry Reports on Pharmaceutical Patent Strategies in South Korea.
